Ramey & Schwaller filed an appeal to the Patent Trial and Appeal Board (PTAB) for Northern Therapeutics, Inc. regarding the rejection of claims 17 and 40 of United States Patent Application Serial Number 11/696,039 by the United States Patent and Trademark Office (USPTO). The PTAB issued its decision reversing the USPTO on July 20, 2016, finding that claims 17 and 40 are enabled by the specification.
Ramey & Schwaller is a full-service intellectual property law firm working with a national client base from our Houston, Texas office. We are dedicated to enhancing client results through efficient practice management, innovative technologies, and the use of skilled professionals.
There are no comments for this post. Be the first and Add your Comment below.
Leave a Comment